fda covid vaccine - Search News

Order byBest matchMost fresh

FDA, COVID-19 and vaccine

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

Vaccine manufacturers will need to conduct "randomized, placebo-controlled trials" before the FDA will approve future applications to give shots to "all healthy persons" between the ages of 6 months ...

· 5h · on MSN

What to know about the FDA plan to restrict COVID vaccines

· 5h

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

· 8h

WA vaccine scientists push back against FDA changes around COVID shots

Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

· 20h

F.D.A. Poised to Restrict Access to Covid Vaccines

· 1d

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 5h

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 21h

New Trump vaccine policy limits access to COVID shots

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

1don MSN

FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”

1don MSN

FDA to limit covid shot approval to elderly, those with medical conditions

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

9hon MSN

Moderna withdraws application for COVID-flu combination vaccine

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.

Explore more

United States

Food and Drug Administration

Novavax